Overview

Neuroprotective Effects of ACTH4-10PRO8-GLY9-PRO10

Status:
Completed
Trial end date:
2021-10-30
Target enrollment:
Participant gender:
Summary
The compound ACTH4-10Pro8-Gly9-Pro10 is a synthetic analog molecule of an adrenocorticotropic hormone (ACTH) short fragment. That is free from hormonal effects and has neuromodulatory effects. We investigate the neuroprotective effects of ACTH4-10Pro8-Gly9-Pro10 can lessen neurotoxicity against ketamine in neonatal rats by looking at BDNF expression in the cortex and hippocampus tissue as well as BDNF blood levels.
Phase:
N/A
Details
Lead Sponsor:
Universitas Sumatera Utara
Treatments:
Ketamine